AstraZeneca Inks $555M AI-CRISPR Deal with Algen to Target Immunology
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.
Microsoft has committed $33 billion to neocloud partnerships, including a $19.4B deal with Nebius, to secure GPU capacity and avoid looming AI infrastructure bottlenecks.
OpenAI has completed a secondary share sale worth $6.6 billion, letting current and former employees sell stock at a new $500 billion valuation — a milestone in the company’s funding strategy.
Elon Musk has broken new ground, achieving a net worth of $500 billion – the first time any person has ever crossed the half-trillion mark, according to Forbes.
AI search startup Perplexity has reportedly raised $200 million at a $20 billion valuation, just two months after a $100 million round – signaling its rapid rise as a major rival to Google.